Ayelet Erez

14PUBLICATIONS

117CO-AUTHORS

Molecular targetsPredictive and prognostic markersCancer cell biologyCancer geneticsCell and nuclear division

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jul 14, 2026

PDE5a Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking Through a Non-canonical cGMP-Dependent Pathway.

|Jan 09, 2026

Inhibition of Tumor Microenvironment-Driven JAK-STAT Signaling Enhances Response to Arginine Deprivation Therapy in Triple-Negative Breast Cancer.

Hila Tishler, Shahar Ziman, Kuoyuan Cheng

|Dec 30, 2025

p53 inactivation drives breast cancer metastasis to the brain through SCD1 upregulation and increased fatty acid metabolism.

Kathrin Laue, Sabina Pozzi, Johanna Zerbib

|Jan 20, 2025

Metabolic interplays between the tumour and the host shape the tumour macroenvironment.

Patricia Altea-Manzano, Amanda Decker-Farrell, Tobias Janowitz

|Jan 10, 2025

Oncogenic IDH1<sup>mut</sup> drives robust loss of histone acetylation and increases chromatin heterogeneity.

Noa Furth, Niv Cohen, Avishay Spitzer

|Jul 04, 2024

Author Correction: ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response.

Lisha Qiu Jin Lim, Lital Adler, Emma Hajaj

Pageof 3

Frequent Collaborators

Eytan Ruppin

Emma Hajaj

Lital N Adler

Yarden Ariav

Noa Furth

Sergey Malitsky

Igor Ulitsky

David Robert Crawford

2 joint publications

Naama Darzi

2 joint publications

Yuri Kuznetsov

Frequent Collaborators

Eytan Ruppin

Emma Hajaj

Lital N Adler

Yarden Ariav